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Antibody-dependent enhancement (ADE) of viral repli-
cation has been documented for viruses, such as dengue
virus, Ross river virus, other alpha and flaviviruses, HIV
and also influenza virus. ADE occurs when non-neutra-
lised virus-antibody complexes find alternative receptors
and routes entry into the cell via the Fc-receptor path-
way. ADE has been demonstrated predominantly in
macrophages or Fc-receptor bearing cells although other
types of cells have also been occasionally implicated
(1,2). Thus, viruses may find routes of entry to cells
lacking the usual virus receptor. Alternatively, the innate
immune signals triggered by virus infection via the FcR
pathway may be different to those triggered by entry via
the physiological virus receptor. Both these conse-
quences may have implications for virus tropism and
pathogenesis. Recently there have been reports of
increased infection rates by pandemic influenza H1N1
virus following receipt of seasonal flu vaccination (3,4).
ADE has been proposed as one mechanism. Here we
illustrate the possible role played by humoral immunity
in providing Influenza A viruses an opportunity to bet-
ter infect immune cells.
Our results showed that, in some cases, prior addition
of human serum to the inoculum triggered an enhanced
infection of target cells as illustrated by a ~2-5 fold
increase in Influenza M-gene copy numbers. Immuno-
fluorescent microscopy revealed that serum-mediated
pdmH1N1 infection led to a higher number of infected
cells. As the fold increase of infected cells paralleled the
fold change in viral gene copies, we conclude that ADE
was acting by increasing the number of infected cells
rather than solely increasing the viral load per cell.
Based on their ability to enhance pdmH1N1 infectiv-
ity, human sera could be divided into 3 distinct groups:
some showing neutralization of infection, others increas-
ing the yield of pdmH1N1-infected cells. The third
group were those with no or marginal increase of virus
infection, one which was not sustained over the tested
range of serum dilutions.
Our results demonstrate that the newly emerged pan-
demic H1N1 Influenza A virus infection of cells of the
hematopoietic lineage may be enhanced by the presence
of some human sera. In the light of the recent studies
that report possible associations between vaccination
and increased susceptibility to influenza infection, it is
of relevance to deepen our understanding of the biologi-
cal significance and molecular mechanisms underlying
serum-mediated ADE infection of influenza virus.
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